Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zinar, Cheryl
NCT05799248: Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management	Recruiting	3	113	US	rhPSMA-7.3 (18F), radiohybrid PSMA-targeted PET imaging agent, Radioligand for PET CT scanning	MidLantic Urology, Blue Earth Diagnostics	Prostate Cancer	05/24	05/24
NCT03945162: Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients	Recruiting	2	125	Canada, US	Ruvidar® (TLD-1433) Bladder infusion and PDT	Theralase® Technologies Inc., University Health Network, Toronto, Pharma eMarket	Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG	06/25	12/25
PRL-02-1001, NCT04729114: A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer	Recruiting	1	174	US	PRL-02 injection, prednisone, dexamethasone, enzalutamide	Astellas Pharma Global Development, Inc.	Prostate Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer	08/25	05/29
AEROLITH, NCT04563039: Acoustic Enhancer Research on Laser Lithotripsy	Active, not recruiting	N/A	196	US	Ureteroscopy Laser Lithotripsy (URS-LL) with Acoustic Enhancer, Standard Ureteroscopic Laser Lithotripsy	Applaud Medical, Inc.	Urinary Stones	06/23	08/24
CHARTER, NCT05437679: Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System	Terminated	N/A	9	US	Blood collection, Data collection	Angle plc, MidLantic Urology, LLC	High Risk Prostate Carcinoma, Biochemically Recurrent Prostate Carcinoma, Castration-resistant Prostate Cancer, Prostate Cancer	08/23	08/23
NCT05250908: INTIBIA Pivotal Study	Active, not recruiting	N/A	208	Europe, US	INTIBIA Therapeutic, INTIBIA Non-Therapeutic	Coloplast A/S	Urinary Incontinence, Urge, Urinary Bladder, Overactive, Urinary Bladder Diseases, Urologic Diseases, Lower Urinary Tract Symptoms, Urological Manifestations	06/25	06/26
Liberatore, Kelly
VAPOR 2, NCT05683691: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer	Active, not recruiting	N/A	400	US	Vanquish System	Francis Medical Inc.	Prostate Cancer	04/27	04/29